Literature DB >> 1891021

Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

A Nomura1, G N Stemmermann, P H Chyou, I Kato, G I Perez-Perez, M J Blaser.   

Abstract

BACKGROUND: Helicobacter pylori are gram-negative spiral bacteria that are associated with chronic gastritis, a known precursor of gastric carcinoma. Persons at high risk for gastric carcinoma have been shown to have a high prevalence of H. pylori infection.
METHODS: We studied the relation of H. pylori infection and gastric carcinoma in a cohort of Japanese American men living in Hawaii. The 5908 men were enrolled and examined from 1967 to 1970. By 1989, 109 cases of pathologically confirmed gastric carcinoma had been identified. The store serum of each patient with gastric carcinoma and of each matched control subject were tested for the presence of serum IgG antibody to H. pylori.
RESULTS: Ninety-four percent of the men with gastric carcinoma and 76 percent of the matched control subjects had a positive test for H. pylori antibodies, for an odds ratio of 6.0 (95 percent confidence interval, 2.1 to 17.3). As the level of antibody to H. pylori increased, there was a progressive increase in the risk of gastric carcinoma (P for trend = 0.0009). The association was strong even for men in whom the diagnosis was made 10 or more years after the serum sample was obtained (odds ratio, 10.5; 95 percent confidence interval, 2.5 to 44.8).
CONCLUSIONS: Infection with H. pylori is strongly associated with an increased risk of gastric carcinoma. However, most persons infected with H. pylori will never have gastric carcinoma. Therefore, other factors that increase the risk of gastric carcinoma among persons infected with H. pylori need to be identified.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1891021     DOI: 10.1056/NEJM199110173251604

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  505 in total

Review 1.  Gastric epithelial dysplasia.

Authors:  G Y Lauwers; R H Riddell
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

2.  Identification of a novel penicillin-binding protein from Helicobacter pylori.

Authors:  P Krishnamurthy; M H Parlow; J Schneider; S Burroughs; C Wickland; N B Vakil; B E Dunn; S H Phadnis
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

3.  Molecular characterization of two-component systems of Helicobacter pylori.

Authors:  D Beier; R Frank
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

4.  Bacterial polymorphisms and disease in humans.

Authors:  M J Blaser; J M Musser
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

5.  Research of Helicobacter pylori infection in precancerous gastric lesions.

Authors:  Xiao-Qiang Zhuang; San-Ren Lin
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

6.  HELICOBACTER PYLORI AND GASTRIC CANCER: IS THERE A LINK?

Authors:  A C Anand; M Anand; P S Reddy; J R Bhardwaj
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 7.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

8.  T-cell, antibody, and cytokine responses to homologs of the 60-kilodalton heat shock protein in Helicobacter pylori infection.

Authors:  S A Sharma; G G Miller; R A Peek; G Pérez-Pérez; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

9.  Helicobacter pylori heat shock protein A: serologic responses and genetic diversity.

Authors:  E K Ng; S A Thompson; G I Pérez-Pérez; I Kansau; A van der Ende; A Labigne; J J Sung; S C Chung; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 10.  An association between Helicobacter pylori and upper respiratory tract disease: fact or fiction?

Authors:  Shin Kariya; Mitsuhiro Okano; Kazunori Nishizaki
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.